1. P626: FUNCTIONAL SCREENING OF PI3K INHIBITORS STRATIFIES RESPONDERS TO IDELALISIB AND INDICATES DRUG CLASS ACTIVITY IN IDELALISIB-REFRACTORY CLL. (23rd June 2022) Authors: Skånland, S.; Yanping, Y.; Athanasiadis, P.; Karlsen, L.; Urban, A.; Murali, I.; Fernandes, S.; Hilli, A.; Taskén, K.; Bertoni, F.; Mato, A.; Normant, E.; Brown, J.; Tjønnfjord, G.; Aittokallio, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗